Document is current

Any future updates will be listed below

Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database

Crossref DOI link: https://doi.org/10.1186/s12885-016-2482-z

Published Online: 2016-07-11

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark